A unique opportunity to learn face-to-face from internationally recognised pricing experts with excellent training competencies
We host tailored events with industry experts, fostering a vibrant community and offering unparalleled networking opportunities. EPP Events provide the knowledge and connections necessary for excelling in the monetization game within your industry.
EPP Webinars are non-sales events designed to immerse you in the latest insights, tools, and best practices on emerging topics.
Access an extensive collection of digital publications to enhance your professional growth
Discover pricing content curated by our partners - your ultimate resource for excpert insights on effective pricing strategies
Edition 3/2018 : Biosimilar pricing in Europe
When a biosimilar enters the market, the reference drug tends to drop in price in the face of competition, whether through internal or external reference pricing or health technology assessment. Janssen’s Remicade (infliximab) serves as the vessel for this exploration into the ways in which European Union Member States, particularly the EU5, have managed the pricing of biosimilars. Germany and the United Kingdom allow free pricing of biosimilars, albeit discounts are expected, whereas France is keen on mandated price cuts and Italy utilizes reference pricing; these procedures serve as a microcosmic representation of biosimilar pricing schemes among Member States.
The EPP® Thought Leadership Series provide insights from pricing leaders around the globe. When a new insight breaks, these pricing leaders already think of the unanswered questions and the story behind the story. These people want to inspire you to act - to take the next step in your journey. With these series, we help to take the right actions.
Join EPP Prime+ now and get direct access to the best resources, weekly updated with new content, webinars, dynamic talks, tools from the EPP Community.
Subscribe your team and benefit from important group discounts